San Francisco, California, July 13, 2017: TMR Research announces a new report on the global renal insufficiency market. The Renal insufficiency market has become a key part of the global healthcare sector in recent years and the dynamics of this market thus carry considerable economic weight, making the study crucial for market parties. The report provides readers with a clear picture of the historical growth trajectory exhibited by the global renal insufficiency market by analyzing the various segments of the market in detail. The geographical dynamics of the global renal insufficiency market are also analyzed in detail in order to better explain the market’s historical background. The report, titled ‘Renal Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,’ further provides reliable 2017-2025 forecasts for the renal insufficiency market based on a comprehensive analysis of the aforementioned data.
Renal insufficiency, also known as kidney failure, has become a key health concern in recent years due to the adoption of unhealthy lifestyles and dietary choices by a growing demographic of urban consumers. The hectic lifestyles of urban consumers in modern times force many to rely on unhealthy but convenient food, leading to a significantly increased risk of renal insufficiency and other kidney problems. The growing prevalence of addictions such as smoking and alcohol has also contributed to the growing prevalence of kidney problems and is likely to remain a key driver for the global renal insufficiency market in the coming years.
Increased government support to the healthcare sector in an increasing number of countries has also been a key driver for the global renal insufficiency market. Advanced treatments for many kidney diseases can be costly and thus require government assistance for wider adoption. The growing awareness regarding the utility of dialysis and the relative ease of acquiring the same is likely to help the renal insufficiency market in the coming years.
The key trend shaping the trajectory of the global renal insufficiency market at present is the inadequacy of existing treatment regimes. This has left significant scope for innovations in the renal insufficiency treatment sector, as widespread unmet need still exists across the world. Research and development avenues are thus likely to remain vital for sustained success in the global renal insufficiency market, and players who focus on new product development are likely to reap the benefits in the coming years.
Leading companies in the global renal insufficiency market include Fresenius Medical Care, Baxter Healthcare, Terumo Corporation, Asahi Kasei Medical Co. Ltd., Fuso Pharmaceutical Industries Ltd., DaVita Healthcare Partners Inc., Nipro Corporation, Gambro AB, and Kawasumi Laboratories Inc.
Regionally, North America is likely to remain the key contributor to the global renal insufficiency market in the 2017-2025 forecast period due to the widespread presence of strong healthcare industry players and the abundance of well-supported medical research avenues. The growing prevalence of kidney diseases in the highly developed U.S. and Canada is likely to ensure consistent government support for the renal insufficiency market in these countries, leading to steady growth of the market through the forecast period.